Navigation Links
CIC Closes Financing Round
Date:1/3/2011

Phoenix is a private equity fund that specializes in making concentrated investments in publicly traded companies in North America. Phoenix is co-managed by Philip Sassower, CEO, and Andrea Goren, Managing Director. Mr. Sassower is currently CIC's Chairman and CEO, while Mr. Goren is the Company's Acting CFO.

Forward Looking StatementsCertain statements contained in this press release, including without limitation, statements containing the words "believes", "anticipates", "hopes", "intends", "expects", and other words of similar import, constitute "forward looking" statements within the meaning of the Private Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors, which may cause actual events to differ materially from expectations.  Such factors include the following (1) technological, engineering, quality control or other circumstances which could delay the sale or shipment of products containing the Company's technology; (2) economic, business, market and competitive conditions in the software industry and technological innovations which could affect the Company's business; (3) the Company's inability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others or prevent others from infringing on the proprietary rights of the Company; and (4) general economic and business conditions and the availability of sufficient financing.Contact Information:CICInvestor Relations & Media Inquiries:Andrea Goren+1.650.802.7723agoren@cic.com
'/>"/>

SOURCE Communication Intelligence Corporation (CIC)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. Mans closest relationship under strain? New research reveals why chimpanzees attack humans
2. Molecular Biometrics Closes $12.5 Million Series B Equity Funding
3. In the war between the sexes, the one with the closest fungal relationship wins
4. CIC to Raise $2.2 Million in Financing and Announces Changes in Management
5. KINAXO Completes Financing Round to Enhance Biomarker Development
6. EmSense Raises $9 Million Series C Round of Financing
7. PDC Biotech GmbH Announces Close of Series A Financing
8. Pacific Biometrics Completes $4 Million Debt Financing
9. Satellite data provide a new way to monitor groundwater in agricultural regions
10. GEN co-sponsors roundtable discussion on novel bioremediation techniques
11. Can cacti escape underground in high temperatures?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... -- --> --> ... Identification System Market by Component (Hardware and Software), Search ... Government, Healthcare, and Transportation) and Geography - Global Forecast ... to be worth USD 8.49 Billion by 2020 at ... The transformation and technology evolution from the manual process ...
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... VIEW, Calif. , Feb. 2, 2016 /PRNewswire/ ... retinopathy market, Frost & Sullivan recognizes US-based Intelligent ... America Frost & Sullivan Award for New Product ... provider in North America , ... in the rapidly growing diabetic retinopathy market. The ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... WARRINGTON, Pa. , Feb. 3, 2016 /PRNewswire/ ... biotechnology company focused on developing aerosolized KL4 surfactant ... Board of Directors has approved an inducement award ... Craig Fraser , its newly appointed President and ... the Board,s Compensation Committee on February 1, 2016 ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 /PRNewswire/ ... HART ), a biotechnology company developing bioengineered organ ... and bronchus, today announced that CEO Jim ... CEO & Investor Conference on Tuesday, February ... New York City . HART,s presentation ...
(Date:2/3/2016)... (PRWEB) , ... February 03, 2016 , ... ... validating a series of potential targets (epitopes) specific to misfolded, propagating strains of ... to create specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from the ...
Breaking Biology Technology: